Adult Pediatric Urology & Urogynecology, PC Performs 250 UroLift® System Treatments for Enlarged Prostate

Share Article

The Board-Certified Urologists of Adult Pediatric Urology & Urogynecology, PC Perform the Most UroLift System Treatments in Omaha, NE

The UroLift System is a long-term durable solution for men suffering from enlarged prostate

John Horgan, M.D., F.A.C.S. of Adult Pediatric Urology & Urogynecology, PC today announced he treated the practice's 250th patient with the UroLift System, a proven, minimally invasive technology to treat men suffering from symptoms associated with Benign Prostatic Hyperplasia, or BPH. Dr. Horgan and his partners were the first physicians to offer the UroLift System in Nebraska and have performed more treatments than anyone else in the state.

“The UroLift System is a long-term durable solution for men suffering from enlarged prostate,” says Dr. Horgan. “Adult Pediatric Urology & Urogynecology, PC is excited to reach the milestone of treating 250 patients with the UroLift System, a truly minimally invasive BPH treatment that involves no heating, cutting or removal of the prostate tissue.” Senior Partner, Euclid de Souza, MD, FACS, adds, “UroLift allows men to get back to their normal lives quickly. Patents are able to discontinue the use of BPH medication and preserve sexual function, which is an important added benefit for men and their partners.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life. 

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring additional treatment for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery. 

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract’s FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the treatment. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at  

About Adult Pediatric Urology & Urogynecology, PC
Wish seven board certified urologists and three board certified urogynecologists, the physicians, providers and staff of Adult Pediatric Urology & Urogynecology are committed to providing innovative, quality patient care in state-of-the-art facilities. Our team of dedicated physicians has been serving residents of Nebraska, Iowa, and South Dakota for more than 25 years. Not only do we have state-of-the-art equipment on-site but we are one of the only facilities in the area to have two urogynecologists on staff.

We evaluate and treat urological disorders in both adults and children and are able to accommodate same-day appointments in most case. We're striving to make appointments as convenient as possible for our patients because we understand the importance and urgency of your issues. Learn more at

To schedule a consultation with Dr. Horgan or Dr. deSouza call (402) 378-9565. 

Media Contact:
Amy Cramer
(650) 391-3714

1 Roehrborn et al. EAU Abstract_ Er Urol Suppl 2017; 16(3):e192. 
2 Sonksen et al J Urology 2016
MAC00359-01 RevB

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Serpa
Health & Commerce
+1 415-676-1923
Email >